Zealand Pharma to Participate in LifeSci Nordic Biotech Summit
Company announcement – No. 40/ 2021 Zealand Pharma to Participate in LifeSci Nordic Biotech Summit Copenhagen, DK and Boston, MA,…
Pharmaceuticals, Biotechnology and Life Sciences
Company announcement – No. 40/ 2021 Zealand Pharma to Participate in LifeSci Nordic Biotech Summit Copenhagen, DK and Boston, MA,…
TUSTIN, Calif., June 22, 2021 (GLOBE NEWSWIRE) — Avid Bioservices, Inc. (NASDAQ:CDMO), a dedicated biologics contract development and manufacturing organization…
Mechelen, Belgium; 22 June 2021, 22.01 CET; regulated information – Galapagos NV (Euronext & NASDAQ: GLPG) announces the departure of…
LEXINGTON, Mass., June 22, 2021 (GLOBE NEWSWIRE) — Keros Therapeutics, Inc. (“Keros”) (Nasdaq: KROS), a clinical-stage biopharmaceutical company focused on…
SOUTH SAN FRANCISCO, Calif., June 22, 2021 (GLOBE NEWSWIRE) — Satsuma Pharmaceuticals, Inc. (Nasdaq: STSA), a clinical-stage biopharmaceutical company developing…
PHILADELPHIA, June 22, 2021 (GLOBE NEWSWIRE) — Century Therapeutics (NASDAQ: IPSC), an innovative biotechnology company developing induced pluripotent stem cell (iPSC)-derived…
NEW HAVEN, Conn., June 22, 2021 (GLOBE NEWSWIRE) — BioXcel Therapeutics, Inc. (the “Company”) (Nasdaq: BTAI), a clinical-stage biopharmaceutical company…
Broad multi-year agreement between Sorrento Therapeutics and U.S. Naval Medical Research Unit – No. 3 (NAMRU-3) headquartered in Sigonella, Italy…
– First selective MET inhibitor approval in China in this setting – – First regulatory approval for the oral, potent and selective…
KIELPIN, Poland, June 22, 2021 (GLOBE NEWSWIRE) — Celon Pharma today announced filing for approval to start a Phase II…